News

Novavax reports revised terms for Takeda agreement for Nuvaxovid in Japan
Novavax (NASDAQ:NVAX) has updated the terms of the previously announced collaboration and licensing agreement with Takeda (NYSE:TAK). The terms of the amended agreement for the development, ...
Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan
Novavax, Inc. (Nasdaq: NVAX) has updated the terms of the previously announced collaboration and licensing agreement (CLA) ...
Novavax, Inc.: Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in Japan
Improved financial terms for Novavax and streamlined operations will help both companies better meet the needs of the Japanese market Nuvaxovid®, a protein-based ...
Novavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In Japan
Novavax, Inc. (NVAX) said it has updated the terms of the collaboration and licensing agreement with Takeda. The company noted that the improved financial terms of the amended ...
Zacks Investment Research on MSN4h
Novavax to Report First-Quarter Earnings: Is a Beat in Store?
We expect Novavax NVAX to surpass expectations when it reports first-quarter 2025 earnings on May 8, before the opening bell.